Previous reports correlating renal function and reamputation after transmetatarsal amputation (TMA) have been mixed. This study aims to evaluate renal function as a factor for reamputation after initial TMA during the perioperative period in a large population database.

Patients who underwent TMA were identified in the American College of Surgeons-National Surgical Quality Improvement Program® database. Reamputation was defined as unplanned TMA or higher-level amputation in the 30-day perioperative period. Glomerular filtration rate (eGFR) was estimated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.

Of 1,775, the rate of reamputation was 6.5%. Reamputation was correlated with higher white blood cell counts (p<.00001), greater serum creatinine (p=.021), higher blood urea nitrogen (p=.021), type of glycemic control (p=.002), stage of CKD (p=.003), and dialysis (p=.001). CKD stage was directly associated with reamputation rates (p=.003) and mortality (p<.00001).

In the current study, CKD predicted reamputation after TMA and 30-day mortality. Our findings corroborate previous reports correlating dialysis-dependent renal failure and mortality. Whether patients in certain stages of CKD would achieve better outcomes with higher-level amputation rather than a TMA requires further study.

graphic
View largeDownload slide
Disclosure

J. Ahn: None. K.M. Raspovic: None. T. Lalli: None. G.T. Liu: Consultant; Self; Gramercy Extremity Orthopedics. M.D. VanPelt: None. D. Wukich: None.

© 2018 by the American Diabetes Association.
2018
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.